Physician profile
Robert O Kwon
NPI 1437193844
$4,784.68
in general payments reported to CMS, 2019-2025
19 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $24.97 · 2021: $33.57 · 2022: $295 · 2023: $2,565 · 2024: $870 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,389 · Honoraria: $1,488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,388.60 |
| Honoraria | $1,487.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,795.54 | 2022-2023 | Tepezza |
| Abbvie INC. | $695.54 | 2022-2025 | |
| Oyster Point Pharma, INC. | $380.43 | 2022-2024 | Tyrvaya |
| Allergan, INC. | $357.76 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $341.05 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $331.73 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Alcon Vision LLC | $270.71 | 2019-2025 | Clareon, Eysuvis, Rocklatan |
| Aerie Pharmaceuticals, INC. | $118.75 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $109.52 | 2024 | Xdemvy |
| Amgen INC. | $101.54 | 2024 | Tepezza |
| Novartis Pharmaceuticals Corporation | $97.73 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $36.74 | 2023-2024 | Eylea Hd |
| Eyevance Pharmaceuticals LLC | $31.66 | 2022-2023 | Flarex |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.97 | 2020 | |
| Biotissue Holdings INC. | $23.93 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beaver-Visitec International, INC. | $20.15 | 2023 | |
| Samsara Vision | $16.92 | 2023 | |
| Iridex Corporation | $16.30 | 2019 | |
| New World Medical,INC. | $13.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.